Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress

Human Molecular Genetics

Volumn 14, Issue 1, 2005, Pages 71-84

  Moore, Darren J ^a   Zhang, Li ^a   Troncoso, Juan ^a   Lee, Michael K ^a   Hattori, Nobutaka ^b   Mizuno, Yoshikuni ^b   Dawson, Ted M ^a   Dawson, Valina L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DETERGENT; DJ 1 PROTEIN; GENE PRODUCT; HEAT SHOCK PROTEIN 70; PARKIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BRAIN REGION; CELL CULTURE; CONTROLLED STUDY; CROSS LINKING; DEMENTIA; DIMERIZATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; HEREDITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEWY BODY; MOLECULAR MECHANICS; MONOGENIC DISORDER; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN STABILITY; SOLUBILITY; UBIQUITINATION;

CELL LINE, TUMOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOCHONDRIA; MUTATION; ONCOGENE PROTEINS; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN BINDING; UBIQUITIN-PROTEIN LIGASES;

HOMO;

EID: 12344251678     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi007     Document Type: Article

References (67)

1. Lang, A.E. and Lozano, A.M. (1998) Parkinson's disease. First of two parts. N. Engl. J. Med., 339, 1044-1053.
2. Lang, A.E. and Lozano, A.M. (1998) Parkinson's disease. Second of two parts. N. Engl. J. Med., 339, 1130-1143.
3. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. and Goedert, M. (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl Acad. Sci. USA, 95, 6469-6473.
4. Gasser, T. (2003) Overview of the genetics of parkinsonism. Adv. Neurol., 91, 143-152.
5. Dawson, T.M. and Dawson, V.L. (2003) Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J. Clin. Invest. 111, 145-151.
6. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
7. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
8. Bonifati, V., Rizzu, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C., Squitieri, F., Ibanez, P., Joosse, M. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256-259.
9. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304, 1158-1160.
10. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet., 18, 106-108.
11. Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B. et al. (2004) The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol., 55, 164-173.
12. Farrer, M., Kachergus, J., Forno, L., Lincoln, S., Wang, D.S., Hulihan, M., Maraganore, D., Gwinn-Hardy, K., Wszolek, Z., Dickson, D. et al. (2004) Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications. Ann. Neurol., 55, 174-179.
13. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. (2003) α-Synuclein locus triplication causes Parkinson's disease. Science, 302, 841.
14. Bonifati, V., De Michele, G., Lucking, C.B., Durr, A., Fabrizio, E., Ambrosio, G., Vanacore, N., De Mari, M., Marconi, R., Capus, L. et al. (2001) The parkin gene and its phenotype. Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Neurol. Sci., 22, 51-52.
15. Mizuno, Y., Hattori, N., Mori, H., Suzuki, T. and Tanaka, K. (2001) Parkin and Parkinson's disease. Curr. Opin. Neurol., 14 477-482.
16. Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl Acad. Sci. USA, 97, 13354-13359.
17. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. et al. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet., 25, 302-305.
18. Imai, Y., Soda, M. and Takahashi, R. (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem., 275, 35661-35664.
19. Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. (2001) Ubiquitination of a new form of α-synuclein by parkin from human brain: implications for Parkinson's disease. Science, 293 263-269.
20. Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. (2001) Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med. 7, 1144-1150.
21. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin. Cell, 105, 891-902.
22. Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron, 37, 735-749.
23. Ren, Y., Zhao, J. and Feng, J. (2003) Parkin binds to α/β tubulin and increases their ubiquitination and degradation. J. Neurosci., 23, 3316-3324.
24. Corti, O., Hampe, C., Koutnikova, H., Darios, F., Jacquier, S., Prigent, A., Robinson, J.C., Pradier, L., Ruberg, M., Mirande, M. et al. (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a parkin substrate: linking protein biosynthesis and neurodegeneration. Hum. Mol. Genet., 12, 1427-1437.
25. Tsai, Y.C., Fishman, P.S., Thakor, N.V. and Oyler, G.A. (2003) Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem., 278, 22044-22055.
26. Huynh, D.P., Scoles, D.R., Nguyen, D. and Pulst, S.M. (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum. Mol. Genet. 12, 2587-2597.
27. Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K.I. and Takahashi, R. (2002) CHIP is associated with parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell, 10, 55-67.
28. Hague, S., Rogaeva, E., Hernandez, D., Gulick, C., Singleton, A., Hanson, M., Johnson, J., Weiser, R., Gallardo, M., Ravina, B. et al. (2003) Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann. Neurol., 54, 271-274.
29. Abou-Sleiman, P.M., Healy, D.G., Quinn, N., Lees, A.J. and Wood, N.W. (2003) The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann. Neurol., 54, 283-286.
30. Hedrich, K., Djarmati, A., Schafer, N., Hering, R., Wellenbrock, C., Weiss, P.H., Hilker, R., Vieregge, P., Ozelius, L.J., Heutink, P. et al. (2004) DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology, 62, 389-394.
31. Clark, L.N., Afridi, S., Mejia-Santana, H., Harris, J., Louis, E.D., Cote, L.J., Andrews, H., Singleton, A., Wavrant De-Vrieze, F., Hardy, J. et al. (2004) Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Movement Disord., 19, 796-800.
32. Hedrich, K., Schafer, N., Hering, R., Hagenah, J., Lanthaler, A.J., Schwinger, E., Kramer, P.L., Ozelius, L.J., Bressman, S.B., Abbruzzese, G. et al. (2004) The R98Q variation in DJ-1 represents a rare polymorphism. Ann. Neurol., 55, 145.
33. Moore, D.J., Zhang, L., Dawson, T.M. and Dawson, V.L. (2003) A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. J. Neurochem., 87, 1558-1567.
34. Miller, D.W., Ahmad, R., Hague, S., Baptista, M.J., Canet-Aviles, R., McLendon, C., Carter, D.M., Zhu, P.P., Stadler, J., Chandran, J. et al. (2003) L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system. J. Biol. Chem., 278, 36588-36595.
35. L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. Hum. Mol. Genet., 12, 2807-2816.
36. Gorner, K., Holtorf, E., Odoy, S., Nuscher, B., Yamamoto, A., Regula, J.T., Beyer, K., Haass, C. and Kahle, P.J. (2004) Differential effects of Parkinson's disease-associated mutations on stability and folding of DJ-1. J. Biol. Chem., 279, 6943-6951.
37. Olzmann, J.A., Brown, K., Wilkinson, K.D., Rees, H.D., Huai, Q., Ke, H., Levey, A.I., Li, L. and Chin, L.S. (2004) Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J. Biol. Chem., 279, 8506-8515.
38. Tao, X. and Tong, L. (2003) Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease. J. Biol. Chem., 278, 31372-31379.
39. Honbou, K., Suzuki, N.N., Horiuchi, M., Niki, T., Taira, T., Ariga, H. and Inagaki, F. (2003) The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. J. Biol. Chem., 278, 31380-31384.
40. Wilson, M.A., Collins, J.L., Hod, Y., Ringe, D. and Petsko, G.A. (2003) The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc. Natl Acad. Sci. USA, 100, 9256-9261.
41. Huai, Q., Sun, Y., Wang, H., Chin, L.S., Li, L., Robinson, H. and Ke, H. (2003) Crystal structure of DJ-1/RS and implication on familial Parkinson's disease. FEBS Lett., 549, 171-175.
42. Lee, S.J., Kim, S.J., Kim, I.K., Ko, J., Jeong, C.S., Kim, G.H., Park, C., Kang, S.O., Suh, P.G., Lee, H.S. et al. (2003) Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. J. Biol. Chem., 278 44552-44559.
43. Wilson, M.A., St Amour, C.V., Collins, J.L., Ringe, D. and Petsko, G.A. (2004) The 1.8-A resolution crystal structure of YDR533Cp from Saccharomyces cerevisiae: a member of the DJ-1/ThiJ/PfpI superfamily. Proc. Natl Acad. Sci. USA, 101, 1531-1536.
44. Kinumi, T., Kimata, J., Taira, T., Ariga, H. and Niki, E. (2004) Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun., 317, 722-728.
45. Taira, T., Saito, Y., Niki, T., Iguchi-Ariga, S.M., Takahashi, K. and Ariga, H. (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep., 5, 213-218.
46. Mitsumoto, A. and Nakagawa, Y. (2001) DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic. Res., 35, 885-893.
47. Mitsumoto, A., Nakagawa, Y., Takeuchi, A., Okawa, K., Iwamatsu, A. and Takanezawa, Y. (2001) Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic. Res., 35, 301-310.
48. Yokota, T., Sugawara, K., Ito, K., Takahashi, R., Ariga, H. and Mizusawa, H. (2003) Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem. Biophys. Res. Commun., 312, 1342-1348.
49. Zhang, Y., Dawson, V.L. and Dawson, T.M. (2000) Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis., 7, 240-250.
50. Dawson, T.M. and Dawson, V.L. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science, 302, 819-822.
51. Sherer, T.B., Kim, J.H., Betarbet, R. and Greenamyre, J.T. (2003) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation. Exp. Neurol. 179, 9-16.
52. Sherer, T.B., Betarbet, R., Stout, A.K., Lund, S., Baptista, M., Panov, A.V., Cookson, M.R. and Greenamyre, J.T. (2002) An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered α-synuclein metabolism and oxidative damage. J. Neurosci., 22, 7006-7015.
53. Manning-Bog, A.B., McCormack, A.L., Li, J., Uversky, V.N., Fink, A.L. and Di Monte, D.A. (2002) The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice: paraquat and alpha-synuclein. J. Biol. Chem., 277, 1641-1644.
54. Lee, S.J. (2003) α-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease? Antioxid. Redox Signal 5, 337-348.
55. Betarbet, R., Sherer, T.B., Di Monte, D.A. and Greenamyre, J.T. (2002) Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol., 12, 499-510.
56. Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V. and Greenamyre, J.T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
57. Chung, K.K., Thomas, B., Li, X., Plemikova, O., Troncoso, J.C., Marsh, L., Dawson, V.L. and Dawson, T.M. (2004) S-Nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science, 304, 1328-1331.
58. Canet-Aviles, R.M., Wilson, M.A., Miller, D.W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M.J., Ringe, D., Petsko, G.A. and Cookson, M.R. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. USA, 101, 9103-9108.
59. Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N. et al. (1999) Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol., 45, 668-672.
60. Hering, R., Strauss, K.M., Tao, X., Bauer, A., Woitalla, D., Mietz, E.M., Petrovic, S., Bauer, P., Schaible, W., Muller, T. et al. (2004) Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7). Hum. Mutat., 24, 321-329.
61. Bonifati, V., Oostra, B.A. and Heutink, P. (2004) Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease. J. Mol. Med., 82, 163-174.
62. Tofaris, G.K., Layfield, R. and Spillantini, M.G. (2001) α-Synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett., 509, 22-26.
63. David, D.C., Layfield, R., Serpell, L., Narain, Y., Goedert, M. and Spillantini, M.G. (2002) Proteasomal degradation of tau protein. J. Neurochem., 83, 176-185.
64. Pawlyk, A.C., Giasson, B.I., Sampathu, D.M., Perez, F.A., Lim, K.L., Dawson, V.L., Dawson, T.M., Palmiter, R.D., Trojanowski, J.Q. and Lee, V.M. (2003) Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age. J. Biol. Chem., 278, 48120-48128.
65. Rizzu, P., Hinkle, D.A., Zhukareva, V., Bonifati, V., Severijnen, L.A., Martinez, D., Ravid, R., Kamphorst, W., Eberwine, J.H., Lee, V.M. et al. (2004) DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. Ann. Neurol., 55, 113-118.
66. Neumann, M., Muller, V., Gorner, K., Kretzschmar, H.A., Haass, C. and Kahle, P.J. (2004) Pathological properties of the Parkinson's disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. Acta Neuropathol. (Berl.), 107, 489-496.
67. Hattori, N., Kitada, T., Matsumine, H., Asakawa, S., Yamamura, Y., Yoshino, H., Kobayashi, T., Yokochi, M., Wang, M., Yoritaka, A. et al. (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann. Neurol., 44, 935-941.